Replies to post #151698 on Biotech Values

[DewDiligence]

Agreed, Vin—I mentioned the effect of exchange rates in #msg-81101403.

[poorgradstudent]

ONXX:

at a 10% quarter to quarter sales increase, Nexavar sales will double in China in TWO years not three.

That's all fine and dandy, but I used the average q/q growth. So I'm not really sure what part of my math you're correcting.

I am not sure why you don't think the increase can hold up.

Simple: Because the 10% q/q increase hasn't held up. Over the last year it was 6.5% q/q on average.

I'll be happy to be wrong, but I'm simply going off as much of the data as are available rather than cherry picking one quarter's growth.